Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis

SIMPLE SUMMARY: Prostate carcinoma (PCa) is the most common tumor in men with an increasing age-associated risk. Several therapy strategies, one of which is docetaxel (DX) chemotherapy, have been established. However, due to the development of therapy resistance, in which chemotherapy no longer effe...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: Markowitsch, Sascha D., Juetter, Kira M., Schupp, Patricia, Hauschulte, Kristine, Vakhrusheva, Olesya, Slade, Kimberly Sue, Thomas, Anita, Tsaur, Igor, Cinatl, Jindrich, Michaelis, Martin, Efferth, Thomas, Haferkamp, Axel, Juengel, Eva
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7923752/
https://ncbi.nlm.nih.gov/pubmed/33672520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040882
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items